• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Arthritis News / Disease Outcomes of Early Non-Radiographic Spondyloarthropathy Explored

Disease Outcomes of Early Non-Radiographic Spondyloarthropathy Explored

March 24, 2009 By Arthritis Center

X-Ray of SondThe spondyloarthropathies (SpA) are a group of related conditions that include ankylosing spondylitis (AS), reactive arthritis, psoriatic arthritis, the arthritis associated with inflammatory bowel disease, and undifferentiated spondyloarthropathy.  Axial involvement (i.e. axial SpA) in these disorders tends to be slowly progressive, requiring in many cases years to decades of clinical symptoms to develop radiographic manifestations.  This lag in objective radiographic findings, combined with a lack of other reliable diagnostic biomarkers for axial SpA, can hamper appropriate early diagnosis and treatment in many patients.  Here, Rudwaleit et al (Arthritis Rheum 2009; 60(3): 717) explore clinical and radiographic outcomes in a prospective cohort comprised of patients with early radiographic and non-radiographic SpA.

Methods

Participants enrolled in the German Spondyloarthritis Inception Cohort (GESPIC) were studied.  To be included, patients had to have inflammatory back pain of less than 10 years duration with radiographic sacroiliac involvement (designated as AS) or without radiographic changes (designated as non-radiographic SpA).  Those with non-radiographic SpA were required to fulfill additional diagnostic criteria, based on a modification of the European Spondyloarthropathy Study Group Criteria.  Participants, enrolled from 13 centers in Germany, were evaluated every 6 months for the first 2 years, and annually thereafter, with clinical, laboratory, and radiographic parameters collected at baseline and longitudinally.

Results

Among the 462 patients were included, 236 were diagnosed with AS at enrollment (51%), of which half had symptoms for less than 5 years.  Patients with non-radiographic SpA (n=226) had symptoms for a mean of 2.6 years.  The proportion of patients receiving therapy with NSAIDs, DMARDs, and TNF inhibitors was similar between the groups.

Comparing AS patients with symptoms less than 5 years to non-radiographic SpA patients, AS patients were more likely to be male (66% vs. 43%; p<0.001); however, there was no difference in age, age at disease onset, HLA-B27 positivity, family history of SpA, proportion with inflammatory back pain, peripheral arthritis, enthesitis, uveitis, dactylitis, psoriasis, or inflammatory bowel disease (currently or reported history).  Among clinical measures, there was no difference in disease activity (measured by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)), overall pain, fatigue, or morning stiffness.

Functional and radiographic measures differed between the groups.  The mean Bath Ankylosing Spondylitis Functional Index (BASFI) was significantly better in non-radiographic SpA patients compared to those with AS (2.5 vs. 3.1, respectively; p<0.001) reflecting overall better spinal mobility and lateral spinal flexion in the non-radiographic SpA group.  Both mean CRP and ESR were significantly higher in AS patients compared to non-radiographic SpA patients (14.4 mg/L vs. 10.9 mg/l, respectively; p<0.001 for CRP and 21 vs 14 mm/hr, respectively; p=0.002 for ESR).  As expected, radiographic sacroiliitis was lower in the non-radiographic SpA groups, but also the occurrence of bridging and non-bridging syndesmophytes.  Male gender and CRP level, but not presence of HLA-B27, were the biggest predictors of radiographic findings, while HLA-B27 was associated with earlier age at onset.  The association of HLA-B27 with age of onset did not differ according to whether the patient has AS or non-radiographic SpA.

Conclusions

Compared to those with AS of comparable disease duration, those with non-radiographic SpA, on average, demonstrated lower levels of systemic inflammation and better function.  Other clinical parameters, such as symptoms, disease features, and the presence of HLA-B27, were not different.

Editorial Comment

This is the largest study, to date, comparing disease features in the early spondyloarthropathies.  One of the most interesting findings revealed by the study is a lack of a difference in clinical symptoms, despite differences in observable damage.  This could suggest that the processes responsible for damage (at least early damage) may be different from those causing symptoms.  This highlights the difficulty that can be encountered in establishing early diagnoses in these patients, who may lack HLA-B27, elevated inflammatory markers, or radiographic evidence of disease, but still may have the same intensity of symptoms as a patient who has these markers.  Longitudinal follow-up on these patients will be key to understanding what early features are associated with development of radiographic damage in the patients without radiographic findings at baseline.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Use of this Site

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Recent News

Exercise Tips for Arthritis Patients

How Does Exercise Affect my Joints? How Frequently Should I Be Exercising? Should I Lose Weight for Exercise to be

Risks and Benefits of Biologic Medications

Victoria Ruffing, RN, BC, Director of Patient Education at the Johns Hopkins Arthritis Center, shares the risks and benefits of biologic for

How to Manage Rheumatoid Arthritis Flares

Through research, doctors have a clearer understanding of how flares can impact a patient on a personal and emotional level. Dr. Uzma Haque

Complementary & Alternative Medicines for Psoriatic Arthritis

There are many complementary & alternative medicines and practices that have been found to be beneficial in curbing arthritis pain,

I can’t be a runner because I have Rheumatoid Arthritis (RA), right?

Dr. Manno discusses running and Rheumatoid Arthritis. Is it an option for the RA patient?

News Categories

  • Ankylosing Spondylitis News
  • Fibromyalgia News
  • Gout News
  • Lupus News
  • Osteoarthritis News
  • Osteoporosis News
  • Psoriatic Arthritis News
  • Rheumatoid Arthritis News
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy